Infectious disease epidemiologist focusing on vaccines and maternal & child health
Katherine is a PhD epidemiologist with over 15 years experience in global health. Her interests and expertise are in the areas of vaccines, maternal & child health, malaria, and health systems strengthening.
She has worked across Africa and South Asia, designing and leading randomised control trials and operational research. Katherine has held roles within WHO and USAID in maternal & child health and malaria prevention, and worked with CHAI and national governments in low-resource settings to advise on vaccine and laboratory health policy and practice for improved health care delivery.
Katherine continues to collaborate with OVG on infant vaccine projects in Nepal, Bangladesh, and Uganda.
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.
Shakya M. et al, (2021), Lancet Glob Health, 9, e1561 - e1568
Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial.
Qadri F. et al, (2021), Lancet, 398, 675 - 684
Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal.
Shakya M. et al, (2019), The New England journal of medicine, 381, 2209 - 2218
Can ITN distribution policies increase children's ITN use? A DHS analysis.
Theiss-Nyland K. et al, (2019), Malar J, 18
Assessing the impact of a VI-polysaccharide conjugate vaccine in preventing typhoid infection among bangladeshi children: A protocol for a phase IIIb Trial
Theiss-Nyland K. et al, (2019), Clinical Infectious Diseases, 68, S74 - S82